CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how CFDs work and can afford the risks. Trading CFDs is high risk and is not suitable for everyone. Refer to our PDS and Target Market Determination. AFSL 513393
Open platformOpen platform

SANUWAVE Health Q3 revenue falls on regulatory uncertainity, lower Ultramist system sales

By Reuters News


Overview

  • Wound care products provider's Q3 revenue fell 24% yr/yr

  • Company posted Q3 operating loss, compared to operating income last year

  • Company says revenue decline driven by regulatory uncertainty and lower Ultramist system sales


Outlook

  • Sanuwave Health did not provide specific financial guidance


Result Drivers

  • REGULATORY UNCERTAINTY - Co said CMS proposed rule led to customer exits and reduced demand, especially among rural home care providers

  • USED EQUIPMENT MARKET - Co said secondary market for used Ultramist systems and uncertainty over 97610 code changes weighed on new system sales

  • CONSUMABLE SALES - Co reported slight increase in Ultramist applicator revenue despite overall sales decline


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Revenue

$8.60 mln

Q3 Net Loss

$1.41 mln

Q3 Gross Margin

77.30%

Q3 Operating Income

-$1.07 mln


Reuters Recommended Reads

  • Nov 9 - Surgery Partners Inc Q3 revenue misses estimates

  • Nov 9 - US FDA orders new eye risk warnings for Ozempic, Zepbound

  • Nov 10 - TELA Bio Q3 revenue misses analyst estimates on lower OviTex PRS volumes


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.